We are preparing the requested document. Please wait, this may take a while...!
|Application / Reactivity||Human|
|Immunocytochemistry (ICC)||1 Antibodies|
|Immunofluorescence (Paraffin-embedded Sections) (IF (p))||21 Antibodies|
|Immunohistochemistry (Frozen Sections) (IHC (fro))||1 Antibodies|
|Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))||8 Antibodies|
|Western Blotting (WB)||9 Antibodies|
|Antigen||Complement Component C9 (C9) Antibodies|
|Epitope||AA 191-220, Center Alternatives|
|Conjugate||This C9 antibody is un-conjugated Alternatives|
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
|3 references available|
|Supplier||Log in to see|
Product Details anti-C9 AntibodyTarget Details C9 Application Details Handling References for anti-C9 Antibody (ABIN657704) Images
|Specificity||This C9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 190-220 amino acids from the Central region of human C9.|
|Purification||This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Immunogen||This C9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 191-220 AA from the Central region of human C9.|
Target Details C9Product Details anti-C9 Antibody Application Details Handling References for anti-C9 Antibody (ABIN657704) Images back to top
|Alternative Name||C9 (C9 Antibody Abstract)|
This gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq].
Synonyms: Complement component C9,C9,
|Molecular Weight||63173 DA|
|Research Area||Phospho-specific antibodies, Cell Signaling, Cell Structure, Protein Modifications|
Application DetailsProduct Details anti-C9 Antibody Target Details C9 Handling References for anti-C9 Antibody (ABIN657704) Images back to top
|Application Notes||WB = 1:1000, IHC (p) = 1:10-50|
|Restrictions||For Research Use only|
HandlingProduct Details anti-C9 Antibody Target Details C9 Application Details References for anti-C9 Antibody (ABIN657704) Images back to top
|Buffer||PBS with 0.09 % (W/V) sodium azide|
|Precaution of Use||This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
|Storage||4 °C/-20 °C|
|Storage Comment||C9 Antibody (Center) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, place the at -20 °C.|
|Expiry Date||6 months|
References for anti-C9 Antibody (ABIN657704)Product Details anti-C9 Antibody Target Details C9 Application Details Handling Images back to top
Rajaraman, Brenner, Neta et al.: "Risk of meningioma and common variation in genes related to innate immunity." in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 19, Issue 5, pp. 1356-61, 2010 (PubMed).
Bunkenborg, Pilch, Podtelejnikov et al.: "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry." in: Proteomics, Vol. 4, Issue 2, pp. 454-65, 2004 (PubMed).
Hofsteenge, Blommers, Hess et al.: "The four terminal components of the complement system are C-mannosylated on multiple tryptophan residues." in: The Journal of biological chemistry, Vol. 274, Issue 46, pp. 32786-94, 2000 (PubMed).
ImagesProduct Details anti-C9 Antibody Target Details C9 Application Details Handling References for anti-C9 Antibody (ABIN657704) back to top